Company Profile

iRhythm Stock Price, News & Analysis

Ticker:
IRTC
Exchange:
NASDAQ
Sector:
MedTech
Location:
United States

Stock performance

112.15 USD (+2.70%)

Close

Last updated: July 27, 2026

3.47B USD

Market cap

Why the stock is moving

As of Jul 27, 2026, IRTC closed up 2.70% at $112.15. No new same-company headline was identified in the current news window.

Company overview

Business overview

iRhythm is a cardiac monitoring company best known for its Zio patch and ambulatory arrhythmia analysis platform.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, iRhythm sits in medical devices and digital diagnostics.

Business Model Characteristics

The business combines device placements, monitoring services, and recurring analysis revenue tied to cardiac detection.

Position Within the Biotechnology Landscape

iRhythm is a digital-diagnostics leader whose stock moves on adoption, reimbursement, and product execution rather than drug data.

Future catalysts

iRhythm's catalysts are Zio monitor adoption, payer coverage, and the pace at which the company can expand its ambulatory cardiac-monitoring footprint. The next step matters because recurring physician and payer adoption is what turns the device into a durable franchise.

Recent news

The five most recent related feed items are shown below in reverse chronological order.

  1. 01
  2. 02
  3. 03
  4. 04

    Encompass Health increases and declares dividend on common stock

    EHC · Source: Encompass Health Corporation

  5. 05

    Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026

    TCMD · Source: Tactile Systems Technology, Inc.

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

Frequently Asked Questions

What is the current stock price of iRhythm (IRTC)?

iRhythm (IRTC) most recently closed at 112.15 USD, a +2.70% move versus the previous session.

What is the market cap of iRhythm (IRTC)?

iRhythm currently has a market capitalization of 3.47B USD on BioPharmSignal.

What does iRhythm do?

iRhythm is a cardiac monitoring company best known for its Zio patch and ambulatory arrhythmia analysis platform.

On which exchange is IRTC stock listed?

iRhythm (IRTC) is associated with NASDAQ, United States, MedTech.

What future catalysts are investors watching for iRhythm?

iRhythm's catalysts are Zio monitor adoption, payer coverage, and the pace at which the company can expand its ambulatory cardiac-monitoring footprint. The next step matters because recurring physician and payer adoption is what turns the device into a durable franchise.